Learning Objectives, Pharmacogenetics, TCPR, October 2014

October 1, 2014



After reading these articles, you should be able to:

  1. Determine some of the pharmacogenetic tests that can possibly play a role in clinical psychiatry.

  2. Describe the uses of pharmacogenetic testing and reasons why a psychiatrist would consider genetic testing on patients.

  3. Explain what is known about the new insomnia drug suvorexant (Belsomra), which was approved by the FDA.

  4. Summarize some of the current findings in the literature regarding psychiatric treatment.


General Psychiatry
    Featured Book
    Featured Video
    Featured Podcast
    • shutterstock_2635946985.jpg
      General Psychiatry

      AI in Practice

      Listen now
    Recommended

    About

    Shop Online

    Newsletters

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.